News

Although dermatography (medical tattooing) is commonly performed around the world as a component of nipple reconstruction after mastectomy, it is rarely used as an adjuvant to enhance the appearance of scars and skin grafts after surgical procedures.

Between 2014 and 2016, the number of cancer survivors living in the United States rose by one million. This is just one of the many benefits the Cancer Progress Reports lists from cancer research.

ASCO clinical practice guideline offers suggests for treating adult cancer survivors with chronic pain.

Most people don't know much about kidney cancer at the time of their diagnosis. The Kidney Cancer Association wants to change that.

Educate, engage and energize — those are the three main verbs and goals of the Bladder Cancer Advocacy Network’s (BCAN) first ever leadership summit.

Olanzapine, an FDA-approved antipsychotic agent, has been shown to improve the prevention of nausea when added to a standard antiemetic.

By funding research and connecting patients with researchers, doctors and clinical trials, End Brain Cancer is hoping that more people will survive the disease.

Children's Brain Tumor Foundation explains the importance of their research and programs.

Chase After a Cure is running a Thunderclap campaign on Sept. 15 and is asking people to be flashy for a good cause: awareness and funds for childhood cancers. - See more at: http://www.curetoday.com/articles/flashy-for-a-cause-raising-awareness-for-childhood-cancers#sthash.uyBvOZyJ.dpuf

Brain cancer has replaced leukemia as the leading type of cancer causing death among children.

Using mobile apps and other new technologies, clinicians can better monitor and help their patients.

Despite obesity as a risk factor for clear cell RCC, a high BMI is a prognostic factor for improved survival in patients with metastatic RCC.

The NOCC is connecting women who have ovarian cancer to others who are experiencing similar struggles.

In the last two decades, global ovarian cancer mortality rates have either levelled or declined.

African American breast cancer survivors experience some specific concerns and risk factors that healthcare practitioners should be aware of when developing survivorship care plans for this population.

Capecitabine, the chemotherapy agent, may cause patients to lose their fingerprints, according to a recent study from the Netherlands.

When we think about the stresses and strains on cancer caregivers in the dawn of the 21st century, the compounded demands on their time and resources must be a first and primary focus.

The nurses that helped Taylor Hendrix during her personal cancer journey led her to pursue a career in oncology nursing.

Cancer survivors are not more likely than the general population to fully engage in healthy lifestyle behaviors. Interventions to increase physical activity and smoking cessation programs are needed.

Deborah Derman used her personal losses and professional experiences to create the new book Colors of Loss and Healing: An Adult Coloring Book for Getting Through Tough Times to help people move forward in their lives.

Music interventions, a category of integrative therapy, can be used to soothe the psychological and physical symptoms and treatment side effects in patients with cancer.

Blinatumomab (Blincyto) gained accelerated approval by the FDA for the treatment of pediatric and adolescent patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL)

Researchers analyzed Bing.com search logs to identify those recently diagnosed with pancreatic cancer. Through symptom patterns expressed as searches, they were able to identify 5% to 15% of pancreatic cancer cases.

Following on a 10-month improvement in progression-free survival (PFS), the FDA has approved ofatumumab (Arzerra) in combination with fludarabine and cyclophosphamide as a treatment for patients with with relapsed chronic lymphocytic leukemia (CLL).

MammaPrint has been shown to improve prediction of clinical outcomes in women with early-stage breast cancer.